Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vladimir Lebedev

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
British Journal of Haematology|May 10, 2019
Rituximab and reduced-intensity chemotherapy in children and adolescents with mature B-cell lymphoma: interim results for 231 patients enrolled in the second Russian-Belorussian multicentre study B-NHL-2010MAlexey Maschan, Natalia Myakova, Olga Aleinikova, et al.
Stem Cells and Cloning : Advances and Applications|November 23, 2018
Use of paracrine factors from stem cells to treat local radiation burns in ratsAndrey Temnov, Tatyana Astrelina, Konstantin Rogov, et al.
Lancet (London, England)|August 2, 2015
Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trialJohn D Grainger, Franco Locatelli, Thirachit Chotsampancharoen, et al.
Journal of Cancer Research and Clinical Oncology|March 7, 2019
Reduced vs. standard dose native E. coli-asparaginase therapy in childhood acute lymphoblastic leukemia: long-term results of the randomized trial Moscow-Berlin 2002Alexander Karachunskiy, Gesche Tallen, Julia Roumiantseva, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
British Journal of Haematology|May 10, 2019
Rituximab and reduced-intensity chemotherapy in children and adolescents with mature B-cell lymphoma: interim results for 231 patients enrolled in the second Russian-Belorussian multicentre study B-NHL-2010MAlexey Maschan, Natalia Myakova, Olga Aleinikova, et al.
Stem Cells and Cloning : Advances and Applications|November 23, 2018
Use of paracrine factors from stem cells to treat local radiation burns in ratsAndrey Temnov, Tatyana Astrelina, Konstantin Rogov, et al.
Lancet (London, England)|August 2, 2015
Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trialJohn D Grainger, Franco Locatelli, Thirachit Chotsampancharoen, et al.
Journal of Cancer Research and Clinical Oncology|March 7, 2019
Reduced vs. standard dose native E. coli-asparaginase therapy in childhood acute lymphoblastic leukemia: long-term results of the randomized trial Moscow-Berlin 2002Alexander Karachunskiy, Gesche Tallen, Julia Roumiantseva, et al.
Pageof 2